Up to 20% of people with PAH have an inherited form of the disease. For example, changes in the BMPR2 gene can be passed down in families. When one parent has the mutation, the child has a 50% ...

Sotatercept-csrk reduced the risk of major morbidity and mortality events in adults with WHO Group 1 PAH FC 3 or 4 at high risk of mortality.